By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Keryx Biopharmaceuticals 

750 Lexington Avenue, 26th Floor

New York  New York  10022  U.S.A.
Phone: 212-531-5965 Fax: 212-531-5961


SEARCH JOBS


Industry
Biotechnology






Company News
Keryx Biopharmaceuticals (KERX) To Host Conference Call On Third Quarter 2014 Financial Results 10/30/2014 8:37:08 AM
Keryx Biopharmaceuticals (KERX) Announces Issuance Of A New U.S. Patent For Ferric Citrate Covering Orally Administrable Forms 10/1/2014 8:55:44 AM
Keryx Biopharmaceuticals (KERX) Initiates Pivotal Phase 3 Study Of Ferric Citrate For The Treatment Of Iron Deficiency Anemia In Patients With Non-Dialysis Dependent Chronic Kidney Disease 9/29/2014 8:57:11 AM
Keryx Biopharmaceuticals (KERX) To Present At The Rodman & Renshaw 16th Annual Global Investment Conference 9/8/2014 7:21:50 AM
FDA Approves Keryx Biopharmaceuticals (KERX)' Kidney Drug Ferric Citrate With Warnings, Shares Crash 9/8/2014 6:25:46 AM
Keryx Biopharmaceuticals (KERX) Announces Second Quarter And Six Month 2014 Financial Results 8/7/2014 8:07:47 AM
Keryx Biopharmaceuticals (KERX) To Host Conference Call On Second Quarter 2014 Financial Results 8/5/2014 8:08:22 AM
Kidney Dialysis Drug Phase 3 Data Boost Keryx Biopharmaceuticals (KERX)'s Hopes For U.S. Approval 7/25/2014 7:40:22 AM
Keryx Biopharmaceuticals (KERX) To Present At The 9th Annual JMP Securities Healthcare Conference 6/18/2014 9:20:09 AM
Keryx Biopharmaceuticals (KERX) Announces Issuance Of Two U.S. Patents For Zerenex(TM) Covering Orally Administrable Forms Of Ferric Citrate 6/18/2014 8:55:20 AM
12345678910...
//-->